LC-MS/MS raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2026-08-01. Anything still debated is marked as such rather than presented as settled.
GW501516 binds and activates PPARδ, a nuclear receptor that influences transcription of genes involved in fatty acid oxidation and energy use. Activation shifts some metabolic pathways in preclinical models, which is why the compound has been studied for lipid disorders and exercise-related endpoints. The exact downstream effects in humans are incompletely mapped. PPARδ is expressed in many tissues, including skeletal muscle, liver, and adipose tissue, so broad activation may have varied consequences. Researchers continue to examine how selective or partial activation might alter the balance between benefits and risks.
Published human data are sparse and mostly come from early-phase trials. Those studies examined short-term changes in lipids, glucose, and exercise capacity, but they were not large enough to establish efficacy or long-term safety. Some animal experiments reported increased running endurance, yet such findings do not prove a performance benefit in people. Anti-doping laboratories detect GW501516 and its metabolites in urine or blood using liquid chromatography-tandem mass spectrometry. Detection windows depend on dose, sample type, and individual metabolism. The method is sensitive enough to identify trace residues in tested samples.
Detection of GW501516 in biological samples generally relies on liquid chromatography coupled with tandem mass spectrometry. Urine is a common matrix in anti-doping analysis, while blood or plasma may be used in research settings. Sample preparation can involve enzymatic hydrolysis, protein precipitation, or solid-phase extraction before instrumental analysis. Because the compound undergoes metabolism, assays may target the parent molecule, one or more metabolites, or both. Detection windows are not fixed; they depend on factors such as dose, route, individual metabolism, and assay sensitivity. Reference standards are required for accurate identification and quantification.
Handling and quality assessment of cardarine reference material follow general laboratory practices for poorly characterized compounds. It typically appears as a white to off-white powder and is sparingly soluble in water but soluble in organic solvents such as dimethyl sulfoxide and ethanol. Storage recommendations usually specify a cool, dry, dark place, with long-term storage at low temperature and desiccation. Purity may be checked by high-performance liquid chromatography with ultraviolet detection, while identity is confirmed by mass spectrometry and nuclear magnetic resonance. No pharmacopeial monograph exists, so reported purity and stability depend on the supplier’s methods.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white solid | Typical form of reference material |
| Solubility | Low in water; soluble in DMSO | Used to prepare stock solutions |
| Typical storage | -20 °C, desiccated, protected from light | Common laboratory practice |
| Analytical method | LC-MS/MS | Detects parent compound and metabolites |
| Common test matrix | Urine or blood | Used in anti-doping analysis |
Legal status varies by country. In some places, cardarine is controlled under medicines or psychoactive substances laws; in others, it may be sold with minimal oversight as a research chemical. Customs agencies have intercepted shipments, and several national health agencies have issued warnings about products marketed for bodybuilding or performance enhancement. The lack of a standardized pharmaceutical supply means identity, purity, and contamination levels can differ widely between samples. These factors make cardarine a regulatory and public health concern rather than a conventional prescription drug.
Cardarine is a common name for GW501516, a synthetic compound first described in the 1990s as a selective agonist of the peroxisome proliferator-activated receptor delta. It was studied in preclinical models for metabolic and cardiovascular conditions, but it has not been approved as a medicine in the United States, Europe, or other major jurisdictions. Retail products labeled as cardarine are generally research chemicals or supplements, not pharmaceutical formulations. Because human safety and efficacy data remain limited, regulatory agencies treat it as an unapproved substance rather than a therapeutic product.
Sporting authorities added GW501516 to prohibited lists after it appeared in athlete samples and online markets. The World Anti-Doping Agency classifies it as a hormone and metabolic modulator, and its use can lead to an anti-doping rule violation. Some early laboratory work suggested effects on fatty acid oxidation and endurance-related metabolism in animals, but those findings do not establish safe or effective use in people. Reports of adverse events in humans are scarce and often anecdotal, which complicates risk assessment.
Preclinical research reported that GW501516 increased running endurance in mice and improved lipid profiles in some animal species. Early human trials explored effects on high-density lipoprotein cholesterol, triglycerides, and glucose handling, but the program was discontinued. Published human data are sparse and do not establish efficacy for any condition. Studies also examined PPAR delta in cancer biology, with conflicting findings across models. The relationship between receptor activation, tissue context, and disease risk remains an active area of investigation.
Anti-doping laboratories identify GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the usual matrix, and detection can occur after the parent compound has cleared from blood. The exact detection window depends on dose, formulation, individual metabolism, and assay sensitivity. Because the compound is prohibited at all times, athletes are subject to testing in and out of competition. Analytical methods continue to improve as new metabolites and designer analogs are characterized.
specific heat capacity (cp) Also massic heat capacity. The heat capacity of a sample of a substance divided by the mass of the sample. Informally, it is the amount of heat that must be added to one unit of mass of the substance in order to cause an increase of one unit in temperature. The SI unit of specific heat capacity is joule per kelvin per kilogram (J/K/kg). Specific heat capacity often varies with temperature and with each state of matter.
The Rocky Mountains, west of the Great Plains, extend north to south across the country, peaking at over 14,000 feet (4,300 m) in Colorado. The supervolcano underlying Yellowstone National Park in the Rocky Mountains, the Yellowstone Caldera, is the continent's largest volcanic feature. Farther west are the rocky Great Basin and the Chihuahuan, Sonoran, and Mojave deserts. In the northwest corner of Arizona, carved by the Colorado River, is the Grand Canyon, a steep-sided canyon and popular tourist destination known for its overwhelming visual size and intricate, colorful landscape. The Cascade and Sierra Nevada mountain ranges run close to the Pacific coast. The lowest and highest points in the contiguous United States are in the state of California, about 84 miles (135 km) apart. Alaska is a state in the northwestern regions of North America. It is a semi-exclave and separated from the contiguous United States. At an elevation of 20,310 feet (6,190.5 m), Alaska's Denali (also called Mount McKinley) is the highest peak in the country and on the continent. Active volcanoes in the U.S. are common throughout Alaska's Alexander and Aleutian Islands, while Hawaii has six active volcanoes, including Kilauea and Mauna Loa. Located entirely outside North America, the Hawaiian archipelago consists of volcanic islands, all physiographically and ethnologically part of the Polynesian subregion of Oceania.
As Canadian pathology society did not have a registry, interested Canadian medical technologists sat for the Amereican ASCP MT certification instead. In 1939, the BOR publishes the first book outlining the educational curriculum for medical technologists entitled Curriculum for Schools of Medical Technology. In 1940, as other organizations began using the same designations, the initials MT(ASCP) were used. In 1944, due to travel wartime restrictions from World War II, the practical component of the certification was discontinued. In 1948, the written essay portion of the certification was deemed too cumbersome to assess, and the certification was switched to a multiple choice and true-false assessment that could be graded on a machine and provide exam statistics. In 1949, the BOR changed the exam format to a 200 multiple choice question exam as the multiple choice questions were found to be a more reliable indicator than true-false questions. In 1949, the BOR also created the Board of Schools (BOS) for registering schools. In 1958, BoR and ASMT assisted with the reclassification of medical technologists, putting them at the professional level in the Civil Service and allowing medical technologists to gain commission status in the US military. In 1962, the BoR began requiring 3 years of college for the MT certification. In 1972, the BoR began requiring a Bachelor's degree for the MT certification. There were 100,000 certificates issued by 1975, 200,000 by 1980, 300,000 by 1991, 400,000 by 2005, and 500,000 by 2014.
== Atom economy == The advantage in atom economy of using NCAs for peptide formation is that there is no need for a protecting group on the functional group reacted with the amino acid. For example, the Merrifield synthesis depends on the use of Boc and Bzl protecting groups, which need be removed after the reaction. In the case of Bailey peptide synthesis, the free peptide is directly obtained after the reaction. However, unwanted and difficult to remove by-products may be formed. An N-substitution of the NCA (for example, by an o-nitrophenylsulfenyl group) can simplify the subsequent purification process, but on the other hand deteriorates the atom economy of the reaction. The synthesis of NCAs can be carried out by the Leuchs reaction or by the reaction of N-(benzyloxycarbonyl)-amino acids with oxalyl chloride. In the latter case, again the procedure is less efficient in the sense of atom economy.
Sources: en.wikipedia.org
== Metabolism == As first discovered in 1882, pyroglutamic acid can be formed by heating glutamic acid at 180 °C, which results in the loss of a molecule of water. In living cells, it is derived from glutathione through the action of an enzyme, γ-glutamyl cyclotransferase. Pyroglutamic acid may function in glutamate storage, and acts to oppose the action of glutamate, including in the brain. It also acts on the brain's cholinergic system; Amyloid β containing pyroglutamic acid is increased in Alzheimer's disease; this may be part of the disease process. Increased levels of pyroglutamic acid in the blood, leading to excess in the urine (5-oxoprolinuria), can occur following paracetamol overdose, as well as in certain inborn errors of metabolism, causing high anion gap metabolic acidosis. Pyroglutamic acid is a natural humectant in skin, and part of its natural moisturizing factor (NMF). Pyroglutamic acid is also present as the N-terminal amino acid in orexin-A, a peptide involved in wakefulness, among other things.
Raines (born 1958), chemical biologist and expert on the chemistry and biology of proteins Mark SaFranko, writer, playwright and actor Kenneth B. Smith (1931–2008), President of the Board of Education of the Chicago Public Schools who also served as President of the Chicago Theological Seminary Leo Sternbach (1908–2005), chemist, invented precursor to Valium Bruce Wands (1949–2022), educator, author, artist, and musician, with a specific interest in digital art Edward Weston (1850–1936), electrical engineer and inventor whose Weston Electrical Instrument Company won the contract to illuminate the Brooklyn Bridge
(2026) determine the ecology of Holocene Eremotherium laurillardi, Notiomastodon platensis, Toxodon platensis, Smilodon populator, Palaeolama major and Xenorhinotherium bahiense from the Jirau and Rio Miranda sites (Brazil) on the basis of the study of the isotopic composition of their teeth, and interpret the Brazilian Intertropical Region as one of the last environmental refuges for the studied mammals. Toledo et al. (2026) compare the complexity of the organization of the manus and pes of extant mammals and extinct xenarthrans and litopterns, reporting evidence of convergences in the organization of limb extremities of litopterns and extant ungulates, and of atypical patterns in xenarthrans. Sotelo et al. (2026) simulate possible future fossil record of extant land mammals, and interpret their findings as indicating that conclusions on the evolution of body mass and diet drawn from the study of the fossil record of mammals might be significantly affected by biases such as incompleteness of the fossil record.
Macrophages can internalize antigens through receptor-mediated phagocytosis. Macrophages have a wide variety of pattern recognition receptors (PRRs) that can recognize microbe-associated molecular patterns (MAMPs) from pathogens. Many PRRs, such as toll-like receptors (TLRs), scavenger receptors (SRs), C-type lectin receptors, among others, recognize pathogens for phagocytosis. Macrophages can also recognize pathogens for phagocytosis indirectly through opsonins, which are molecules that attach to pathogens and mark them for phagocytosis. Opsonins can cause a stronger adhesion between the macrophage and pathogen during phagocytosis, hence opsonins tend to enhance macrophages' phagocytic activity. Both complement proteins and antibodies can bind to antigens and opsonize them. Macrophages have complement receptor 1 (CR1) and 3 (CR3) that recognize pathogen-bound complement proteins C3b and iC3b, respectively, as well as fragment crystallizable γ receptors (FcγRs) that recognize the fragment crystallizable (Fc) region of antigen-bound immunoglobulin G (IgG) antibodies. When phagocytosing and digesting pathogens, macrophages go through a respiratory burst where more oxygen is consumed to supply the energy required for producing reactive oxygen species (ROS) and other antimicrobial molecules that digest the consumed pathogens.
== Signs and symptoms == Physical symptoms of CMRD involving the development and function of the gastrointestinal tract and nervous system typically manifest between infancy and adolescence. The symptoms of CmRD are similar to the physical symptoms of malnutrition, as the disease arises due to the poor absorption of lipids and fat-soluble nutrients such as vitamin E. For this reason, the disease is likely to be underdiagnosed by physicians. Fat-soluble nutrients are essential for growth, development, and normal bodily function. Vitamin E deficiency is especially serious, as the vitamin is necessary for proper neurological function and development. Without Vitamin E, neurons cannot operate correctly and signals from the brain are weakened. This leads to reduced muscle development and reduced muscle contraction. Symptoms that manifest in the GI tract are likely to be a consequence of both reduced absorption of fats and physiological stress imposed on enterocytes that can not shuttle fats into circulation. Additional symptoms that occur throughout the body can be attributed to the lack of sufficient lipid sources.
Sources: en.wikipedia.org
Calcetriol is the active form of vitamin D3 found in the kidneys. The enzyme can further oxidise calcitetrol, leading finally to calcitroic acid. Calcifediol also acts as a substrate and is oxidised to the corresponding 24-hydroxy compound, secalciferol.
Early lichenologists later reclassified the species in different genera. For instance, Erik Acharius (1803) referred to it as Parmelia parietina in his work Methodus, and Giuseppe De Notaris (1847) listed it as Physcia parietina. Johannes M. Norman (1852) treated it under Teloschistes (a related genus of orange-colored lichens), calling it Teloschistes parietinus. The modern genus Xanthoria was established by Theodor Fries. In 1860, he formally recombined the species as Xanthoria parietina. In his treatment, Fries recognized a distinct form, which he called Xanthoria aureola, distinguishing it from the more common form of X. parietina. He described aureola as a primary and fundamental form of the species, particularly prevalent in Arctic regions, differing from typical X. parietina in its color, rigid thallus, and preference for exposed habitats. Fries also cited Acharius, who considered aureola an intermediate between Xanthoria elegans (now Rusavskia elegans) and X. parietina. These distinctions may have contributed to later taxonomic interpretations that recognized Xanthoria aureola as a separate species. Xanthoria parietina is the type species of the genus Xanthoria. The designated lectotype for Xanthoria parietina is the illustration cited by Linnaeus from Dillenius (1742). Due to its reclassification across different genera, Xanthoria parietina has accumulated many synonyms in the literature. In addition to generic transfers, various infraspecific taxa (forms, varieties, or subspecies) have been described, particularly regarding morphological variants.
Gregory L. Verdine (born June 10, 1959) is an American chemical biologist, biotech entrepreneur, venture capitalist and university professor. He is a founder of the field of chemical biology, which deals with the application of chemical techniques to biological systems. His work has focused on mechanisms of DNA repair and cell penetrability. Verdine is the co-inventor with Christian Schafmeister of stapled peptides, a new class of drugs that combines the versatile binding properties of monoclonal antibodies with the cell-penetrating ability of small molecules. Verdine coined the term "drugging the undruggable" to describe the unique capabilities of stapled peptides. A close analog of a stapled peptide drug invented in the Verdine Lab, sulanemadlin (ALRN-6924), is a first-in-class dual MDM2/MDMX inhibitor currently in Phase II clinical development by Aileron Therapeutics, which he co-founded in 2005. FogPharma, founded in 2016, aims to further develop stapled peptide technology for therapeutic use. He has founded numerous other drug discovery companies, including six that are listed on the NASDAQ. His companies have succeeded in developing two FDA-approved drugs, romidepsin and paritaprevir, which are, respectively, an anticancer agent used in cutaneous T-cell lymphoma (CTCL) and other peripheral T-cell lymphomas (PTCLs), and an acylsulfonamide inhibitor that is used to treat chronic hepatitis C.
=== Public transportation statistics === The average amount of time people spend commuting with public transit in Turin (for example, to and from work) on a weekday is 65 minutes. 14% of public transit riders ride for more than 2 hours every day. The average time spent waiting at a stop or station for public transit is 14 minutes, while 19% of riders wait for over 20 minutes on average every day. The average distance people usually ride in a single trip with public transit is 5.9 km (3.7 mi), while 9% travel more than 12 km (7.5 mi) in a single direction.
Sources: en.wikipedia.org
Anti-doping and clinical laboratories commonly use liquid chromatography-tandem mass spectrometry. The method can identify GW501516 and its metabolites in urine or blood. Detection depends on sample timing and the amount present.
PPARδ is a nuclear receptor that regulates genes linked to fatty acid oxidation and energy metabolism. Activation can alter lipid handling and energy use in experimental models. The full range of effects in humans is still under study.
The solid compound is generally stable when kept cold, dry, and protected from light. Solutions may degrade faster, so laboratory protocols often specify fresh preparation or cold storage. Stability can depend on solvent, concentration, and container.
Cardarine targets PPARδ, a nuclear receptor involved in lipid and energy metabolism. It does not bind the androgen receptor in the way SARMs do.